Gallinamide A (TFA)
Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM) . Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM) . Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM) [1][2].
Product Specifications
CAS Number
1352920-57-0
UNSPSC
12352005
Target
Cathepsin; Parasite; SARS-CoV
Type
Natural Products
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gallinamide-a-tfa.html
Purity
99.85
Solubility
10 mM in DMSO
Smiles
CC[C@H](C)[C@H](N(C)C)C(O[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](C)/C=C/C(N1[C@H](C(OC)=CC1=O)C)=O)=O)=O)=O.OC(C(F)(F)F)=O
Molecular Formula
C33H53F3N4O9
Molecular Weight
706.79
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Collagen II (COL2A1) Human Gene Knockout Kit (CRISPR)
CD63 (Late Endosomes Marker) (rMX-49.129.5), CF647 conjugate, 0.1mg/mL
